K-PAX Pharmaceuticals is interested in working with investors and industry partners to support the further development of KPAX002.

Questions regarding investment opportunities can be directed to K-PAX's Director of Operations, Anne Lahaderne at: This email address is being protected from spambots. You need JavaScript enabled to view it. of by calling (415) 381-7565.